These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8357779)

  • 1. Effects of cicletanine on the urinary excretion of prostanoids and kallikrein, and on renal function in man.
    Tsunoda K; Abe K; Omata K; Hagino T; Minami N; Munakata M; Yoshida K; Sakuma H; Misawa S; Arima S
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):253-6. PubMed ID: 8357779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids.
    Ferry N; Geoffroy J; Pozet N; Cuisinaud G; Benzoni D; Zech PY; Sassard J
    Br J Clin Pharmacol; 1988 Mar; 25(3):359-66. PubMed ID: 3358898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats.
    Emond C; Bompart G; Rakotoarivony J; Bascands JL; Pecher C; Adam A; Tarrade T; Berthet P; Girolami JP
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):601-8. PubMed ID: 1280717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects.
    Moulin B; Fillastre JP; Godin M; Coquerel A; Decoopman E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):292-9. PubMed ID: 7752655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
    Ogawa K; Ito T; Ban M; Mochizuki M; Satake T
    Klin Wochenschr; 1985 Apr; 63(7):332-6. PubMed ID: 3889484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cicletanine on vasoactive systems in conscious sinoaortic-denervated dogs.
    Damase-Michel C; Girolami JP; Bascands JL; Tran MA; Moatti JP; Pecher C; Berthet P; Tarrade T; Montastruc JL
    Fundam Clin Pharmacol; 1991; 5(8):719-32. PubMed ID: 1783361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal responses to magnesium lithospermate B.
    Yokozawa T; Lee TW; Chung HY; Oura H; Nonaka G; Nishioka I
    J Pharm Pharmacol; 1990 Oct; 42(10):712-5. PubMed ID: 1982144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Metsä-Ketelä T; Tuomisto L; Manninen V; Vapaatalo H
    J Pharmacol Exp Ther; 1986 Apr; 237(1):246-51. PubMed ID: 3007740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function.
    Harvey JN; Edmundson AW; Jaffa AA; Martin LL; Mayfield RK
    Diabetologia; 1992 Sep; 35(9):857-62. PubMed ID: 1397781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cicletanine on renal cGMP production.
    Valdivielso JM; Morales AI; Pérez-Barriocanal F; López-Novoa JM
    Can J Physiol Pharmacol; 1998 Dec; 76(12):1151-5. PubMed ID: 10326838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cicletanine on the progression of renal failure in 5/6 nephrectomized hypertensive rats.
    Nakamoto H; Suzuki H; Ohishi A; Katsumata H; Sakaguchi H; Saruta T
    Clin Exp Pharmacol Physiol; 1999 Mar; 26(3):236-41. PubMed ID: 10081620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
    Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
    Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the effects of cicletanine on prostanoids.
    Guinot P; Frölich JC
    Arzneimittelforschung; 1985; 35(11):1714-6. PubMed ID: 3867354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduction of kidney prostaglandin synthesis in patients with essential hypertension. Stimulating effect of cicletanine].
    Hornych A; Boisson J; Gaschard JC
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():85-90. PubMed ID: 2514674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.
    Zacharieva S; Koev D; Andonova K
    Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin--kallikrein--prostaglandin system: plasma active and inactive renin and urinary kallikrein during prostacyclin infusion in man.
    FitzGerald GA; Hossmann V; Hummerich W; Konrads A
    Prostaglandins Med; 1980 Dec; 5(6):445-56. PubMed ID: 7008062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
    Säynävälammi P
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.